FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947789919> ?p ?o ?g. }

• W2947789919 endingPage "1129" @default.
• W2947789919 startingPage "1118" @default.
• W2947789919 abstract "Oligonucleotide drugs are experiencing greater success in the clinic, encouraging the initiation of new projects. Resources are insufficient to develop every potentially important project, and persuasive experimental data using cell lines close to disease target tissue is needed to prioritize candidates. Friedreich's ataxia (FRDA) is a devastating and currently incurable disease caused by insufficient expression of the enzyme frataxin (FXN). We have previously shown that synthetic nucleic acids can activate FXN expression in human patient-derived fibroblast cells. We chose to further test these compounds in induced pluripotent stem cell-derived neuronal progenitor cells (iPSC-NPCs). Here we describe methods to deliver oligonucleotides and duplex RNAs into iPSC-NPCs using electroporation. Activation of FXN expression is potent, easily reproducible, and potencies parallel those determined using patient-derived fibroblast cells. A duplex RNA and several antisense oligonucleotides (ASOs) with different combinations of 2′-methoxyethyl (2′-MOE), 2′-fluoro (2′-F), and constrained ethyl (cEt) were active, providing multiple starting points for further development and highlighting improved potency as an important goal for preclinical development. Our data support the conclusion that ASO-mediated activation of FXN is a feasible approach for treating FRDA and that electroporation is a robust method for introducing ASOs to modulate gene expressions in neuronal cells." @default.
• W2947789919 created "2019-06-07" @default.
• W2947789919 creator A5006154160 @default.
• W2947789919 creator A5037942759 @default.
• W2947789919 creator A5041605141 @default.
• W2947789919 creator A5044865944 @default.
• W2947789919 creator A5048905983 @default.
• W2947789919 creator A5062765373 @default.
• W2947789919 creator A5077095079 @default.
• W2947789919 creator A5082453888 @default.
• W2947789919 date "2019-05-31" @default.
• W2947789919 modified "2023-10-15" @default.
• W2947789919 title "Efficient electroporation of neuronal cells using synthetic oligonucleotides: identifying duplex RNA and antisense oligonucleotide activators of human frataxin expression" @default.
• W2947789919 cites W1964514885 @default.
• W2947789919 cites W1975651897 @default.
• W2947789919 cites W1975933947 @default.
• W2947789919 cites W1984131396 @default.
• W2947789919 cites W2002053669 @default.
• W2947789919 cites W2028269121 @default.
• W2947789919 cites W2044375974 @default.
• W2947789919 cites W2045617609 @default.
• W2947789919 cites W2050876258 @default.
• W2947789919 cites W2087786585 @default.
• W2947789919 cites W2095013780 @default.
• W2947789919 cites W2116633214 @default.
• W2947789919 cites W2126432370 @default.
• W2947789919 cites W2126928912 @default.
• W2947789919 cites W2142275018 @default.
• W2947789919 cites W2155385687 @default.
• W2947789919 cites W2293120410 @default.
• W2947789919 cites W2302360713 @default.
• W2947789919 cites W2312976925 @default.
• W2947789919 cites W2468705417 @default.
• W2947789919 cites W2561412303 @default.
• W2947789919 cites W2577713652 @default.
• W2947789919 cites W2587479628 @default.
• W2947789919 cites W2588486271 @default.
• W2947789919 cites W2605279931 @default.
• W2947789919 cites W2770498368 @default.
• W2947789919 cites W2771932281 @default.
• W2947789919 cites W2775795482 @default.
• W2947789919 cites W2783022904 @default.
• W2947789919 cites W2787072049 @default.
• W2947789919 cites W2802376313 @default.
• W2947789919 cites W2805477090 @default.
• W2947789919 cites W2883699765 @default.
• W2947789919 cites W2886103485 @default.
• W2947789919 cites W2886828822 @default.
• W2947789919 cites W2888067681 @default.
• W2947789919 cites W2893168313 @default.
• W2947789919 cites W2897063898 @default.
• W2947789919 cites W4233394827 @default.
• W2947789919 doi "https://doi.org/10.1261/rna.071290.119" @default.
• W2947789919 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6800520" @default.
• W2947789919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31151992" @default.
• W2947789919 hasPublicationYear "2019" @default.
• W2947789919 type Work @default.
• W2947789919 sameAs 2947789919 @default.
• W2947789919 citedByCount "15" @default.
• W2947789919 countsByYear W29477899192019 @default.
• W2947789919 countsByYear W29477899192020 @default.
• W2947789919 countsByYear W29477899192021 @default.
• W2947789919 countsByYear W29477899192022 @default.
• W2947789919 countsByYear W29477899192023 @default.
• W2947789919 crossrefType "journal-article" @default.
• W2947789919 hasAuthorship W2947789919A5006154160 @default.
• W2947789919 hasAuthorship W2947789919A5037942759 @default.
• W2947789919 hasAuthorship W2947789919A5041605141 @default.
• W2947789919 hasAuthorship W2947789919A5044865944 @default.
• W2947789919 hasAuthorship W2947789919A5048905983 @default.
• W2947789919 hasAuthorship W2947789919A5062765373 @default.
• W2947789919 hasAuthorship W2947789919A5077095079 @default.
• W2947789919 hasAuthorship W2947789919A5082453888 @default.
• W2947789919 hasBestOaLocation W29477899191 @default.
• W2947789919 hasConcept C104317684 @default.
• W2947789919 hasConcept C107459253 @default.
• W2947789919 hasConcept C129312508 @default.
• W2947789919 hasConcept C145103041 @default.
• W2947789919 hasConcept C150194340 @default.
• W2947789919 hasConcept C153911025 @default.
• W2947789919 hasConcept C186852380 @default.
• W2947789919 hasConcept C200886947 @default.
• W2947789919 hasConcept C2779314966 @default.
• W2947789919 hasConcept C28859421 @default.
• W2947789919 hasConcept C55493867 @default.
• W2947789919 hasConcept C67705224 @default.
• W2947789919 hasConcept C70721500 @default.
• W2947789919 hasConcept C86803240 @default.
• W2947789919 hasConcept C95444343 @default.
• W2947789919 hasConceptScore W2947789919C104317684 @default.
• W2947789919 hasConceptScore W2947789919C107459253 @default.
• W2947789919 hasConceptScore W2947789919C129312508 @default.
• W2947789919 hasConceptScore W2947789919C145103041 @default.
• W2947789919 hasConceptScore W2947789919C150194340 @default.
• W2947789919 hasConceptScore W2947789919C153911025 @default.
• W2947789919 hasConceptScore W2947789919C186852380 @default.
• W2947789919 hasConceptScore W2947789919C200886947 @default.
• W2947789919 hasConceptScore W2947789919C2779314966 @default.

• next